133 related articles for article (PubMed ID: 19545132)
1. Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis.
Zhao Y; Bacher A; Illarionov B; Fischer M; Georg G; Ye QZ; Fanwick PE; Franzblau SG; Wan B; Cushman M
J Org Chem; 2009 Aug; 74(15):5297-303. PubMed ID: 19545132
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
3. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 6, 7-dimethoxy-3-(4-pyridyl)-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-yl-4-substituted phenylmethanone/ethanone derivatives.
Ali MA; Ismail R; Choon TS; Elumalai M; Kumar S; Osman H; Govidasamy J; Yadav R; Yadav G; Kour R; Vyas S
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):155-9. PubMed ID: 21635209
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.
Talukdar A; Illarionov B; Bacher A; Fischer M; Cushman M
J Org Chem; 2007 Sep; 72(19):7167-75. PubMed ID: 17696548
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.
Brunner K; Maric S; Reshma RS; Almqvist H; Seashore-Ludlow B; Gustavsson AL; Poyraz Ö; Yogeeswari P; Lundbäck T; Vallin M; Sriram D; Schnell R; Schneider G
J Med Chem; 2016 Jul; 59(14):6848-59. PubMed ID: 27379713
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
Fullam E; Talbot J; Abuhammed A; Westwood I; Davies SG; Russell AJ; Sim E
Bioorg Med Chem Lett; 2013 May; 23(9):2759-64. PubMed ID: 23518278
[TBL] [Abstract][Full Text] [Related]
11. A new series of N-[2,4-dioxo-6-d-ribitylamino-1,2,3,4-tetrahydropyrimidin-5-yl]oxalamic acid derivatives as inhibitors of lumazine synthase and riboflavin synthase: design, synthesis, biochemical evaluation, crystallography, and mechanistic implications.
Zhang Y; Illarionov B; Morgunova E; Jin G; Bacher A; Fischer M; Ladenstein R; Cushman M
J Org Chem; 2008 Apr; 73(7):2715-24. PubMed ID: 18331058
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel methanone derivatives acting as antimycobacterial agents.
Ali MA; Bastian S; Ismail R; Choon TS; Ali S; Aubry A; Pandian S; Saraswat P; Singh A; Gaur R
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):890-4. PubMed ID: 21395486
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biochemical evaluation of 1,5,6,7-tetrahydro-6,7-dioxo-9-D-ribitylaminolumazines bearing alkyl phosphate substituents as inhibitors of lumazine synthase and riboflavin synthase.
Cushman M; Jin G; Sambaiah T; Illarionov B; Fischer M; Ladenstein R; Bacher A
J Org Chem; 2005 Sep; 70(20):8162-70. PubMed ID: 16277343
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase.
Concha N; Huang J; Bai X; Benowitz A; Brady P; Grady LC; Kryn LH; Holmes D; Ingraham K; Jin Q; Pothier Kaushansky L; McCloskey L; Messer JA; O'Keefe H; Patel A; Satz AL; Sinnamon RH; Schneck J; Skinner SR; Summerfield J; Taylor A; Taylor JD; Evindar G; Stavenger RA
J Med Chem; 2016 Aug; 59(15):7299-304. PubMed ID: 27379833
[TBL] [Abstract][Full Text] [Related]
19. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
